• David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

  • Feb 4 2025
  • Durée: 47 min
  • Podcast

David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will be available until January 26, 2026.

    Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by an independent educational grant from AstraZeneca.

    Disclosure information is available at the beginning of the video presentation.

    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.